156 related articles for article (PubMed ID: 18256400)
1. Pharmacogenomic biomarkers for prediction of severe adverse drug reactions.
Ingelman-Sundberg M
N Engl J Med; 2008 Feb; 358(6):637-9. PubMed ID: 18256400
[No Abstract] [Full Text] [Related]
2. Abacavir hypersensitivity.
Vandekerckhove L; Blot S; Vogelaers D
N Engl J Med; 2008 Jun; 358(23):2514-5; author reply 2515-6. PubMed ID: 18525052
[No Abstract] [Full Text] [Related]
3. Pharmacogenomics testing for type B adverse drug reactions to anti-infective drugs: the example of hypersensitivity to abacavir.
Agundez JA; Esguevillas G; Amo G; Garcia-Martin E
Recent Pat Antiinfect Drug Discov; 2014; 9(2):151. PubMed ID: 25891395
[No Abstract] [Full Text] [Related]
4. Use of patch testing for the diagnosis of abacavir-related hypersensitivity reaction in HIV patients.
Giorgini S; Martinelli C; Tognetti L; Carocci A; Giuntini R; Mastronardi V; Torricelli F; Leoncini F; Lotti T
Dermatol Ther; 2011; 24(6):591-4. PubMed ID: 22515676
[TBL] [Abstract][Full Text] [Related]
5. Abacavir hypersensitivity reaction predicted by genetic test.
AIDS Treat News; 2004 Mar; (399):6. PubMed ID: 15199868
[TBL] [Abstract][Full Text] [Related]
6. HLA-B*5701 screening for hypersensitivity to abacavir.
Mallal S; Phillips E; Carosi G; Molina JM; Workman C; Tomazic J; Jägel-Guedes E; Rugina S; Kozyrev O; Cid JF; Hay P; Nolan D; Hughes S; Hughes A; Ryan S; Fitch N; Thorborn D; Benbow A;
N Engl J Med; 2008 Feb; 358(6):568-79. PubMed ID: 18256392
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility.
Hughes AR; Spreen WR; Mosteller M; Warren LL; Lai EH; Brothers CH; Cox C; Nelsen AJ; Hughes S; Thorborn DE; Stancil B; Hetherington SV; Burns DK; Roses AD
Pharmacogenomics J; 2008 Dec; 8(6):365-74. PubMed ID: 18332899
[TBL] [Abstract][Full Text] [Related]
8. The convenience of flow cytometry for HLA-B*5701 screening to prevent abacavir hypersensitivity reactions.
Airo P; Scarsi M; Malagoli A; Carella G; Izzo I; Carosi G; Torti C
J Acquir Immune Defic Syndr; 2009 Jul; 51(3):361-2. PubMed ID: 19553774
[No Abstract] [Full Text] [Related]
9. Abacavir hypersensitivity.
Abel S; Paturel L; Cabié A
N Engl J Med; 2008 Jun; 358(23):2515; author reply 2515-6. PubMed ID: 18536095
[No Abstract] [Full Text] [Related]
10. Current trends in screening across ethnicities for hypersensitivity to abacavir.
Rodriguez-Nóvoa S; Soriano V
Pharmacogenomics; 2008 Oct; 9(10):1531-41. PubMed ID: 18855539
[TBL] [Abstract][Full Text] [Related]
11. Genetic association studies to detect adverse drug reactions: abacavir hypersensitivity as an example.
Hughes AR; Brothers CH; Mosteller M; Spreen WR; Burns DK
Pharmacogenomics; 2009 Feb; 10(2):225-33. PubMed ID: 19207023
[TBL] [Abstract][Full Text] [Related]
12. HLA-B*5701 screening for susceptibility to abacavir hypersensitivity.
Lucas A; Nolan D; Mallal S
J Antimicrob Chemother; 2007 Apr; 59(4):591-3. PubMed ID: 17317695
[TBL] [Abstract][Full Text] [Related]
13. Complications and side effects. Abacavir hypersensitivity testing results--Montreal.
TreatmentUpdate; 2007; 19(5):8-9. PubMed ID: 17955617
[No Abstract] [Full Text] [Related]
14. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.
Hetherington S; Hughes AR; Mosteller M; Shortino D; Baker KL; Spreen W; Lai E; Davies K; Handley A; Dow DJ; Fling ME; Stocum M; Bowman C; Thurmond LM; Roses AD
Lancet; 2002 Mar; 359(9312):1121-2. PubMed ID: 11943262
[TBL] [Abstract][Full Text] [Related]
15. HLA-B*5701 Genotyping for Abacavir Prescription: Re-Examination of its Cost-Effectiveness in Singapore.
Goh KS; Kapoor R; Lee CC; Ng CY; Leong KP
Ann Acad Med Singap; 2019 Apr; 48(4):133-138. PubMed ID: 31131386
[No Abstract] [Full Text] [Related]
16. Labeling changes for abacavir.
AIDS Patient Care STDS; 2008 Aug; 22(8):683-4. PubMed ID: 18721055
[No Abstract] [Full Text] [Related]
17. Genetic screening to prevent abacavir hypersensitivity reaction: are we there yet?
Phillips EJ
Clin Infect Dis; 2006 Jul; 43(1):103-5. PubMed ID: 16758425
[No Abstract] [Full Text] [Related]
18. Prospective HLA-B*5701 screening and abacavir hypersensitivity: a single centre experience.
Waters LJ; Mandalia S; Gazzard B; Nelson M
AIDS; 2007 Nov; 21(18):2533-4. PubMed ID: 18025891
[TBL] [Abstract][Full Text] [Related]
19. Severe abacavir hypersensitivity reaction in a patient tested HLA-B*5701 negative.
Bonta PI; Vermeulen JN; Speelman P; Prins JM
AIDS; 2008 Jul; 22(12):1522-3. PubMed ID: 18614879
[No Abstract] [Full Text] [Related]
20. [HLA-B*5701 and abacavir hypersensitivity reaction].
Servonnet A; Leclercq E; Delacour H; Ceppa F
Pathol Biol (Paris); 2010 Dec; 58(6):e95-100. PubMed ID: 19243901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
